Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10060318HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10057898HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10060329HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10059008HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10061254HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10059347HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10059009HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10059010HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10062374HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10059012HBVENSG00000163631.19protein_codingALBNoNo213P02768
TCGA Plot Options
Drug Information
GeneALB
DrugBank IDDB06713
Drug NameNorelgestromin
Target IDBE0000530
UniProt IDP02768
Regulation Type
PubMed IDs12586319
CitationsHammond GL, Abrams LS, Creasy GW, Natarajan J, Allen JG, Siiteri PK: Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties. Contraception. 2003 Feb;67(2):93-9.
GroupsApproved; Investigational
Direct ClassificationEstrane steroids
SMILES[H][C@@]12CC[C@@](O)(C#C)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(C=C3CC[C@@]21[H])=NO
Pathways
PharmGKB
ChEMBLCHEMBL1200807